Researchers at Simon Fraser University reveal how brain imaging techniques can explain the inconsistent effects of levodopa ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

Simon Fraser University researchers are pioneering personalized Parkinson's treatment using MEG imaging. They discovered that ...

Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to ...

Abstract Abstract. Levodopa is the most efficacious agent for the treatment of motor features of Parkinson's disease but its chronic use is associated with the development of motor complications.

People with Parkinson’s disease may experience a range of movement-related symptoms, such as tremors, slow movement, stiffness and balance problems. Wiesman hopes that a better understanding of how ...

Background A 48-year-old man with a 9-year history of Parkinson's disease who had previously shown a good response to levodopa presented for evaluation of increasingly disabling motor fluctuations ...

Roche and Prothena are advancing Prasinezumab to Phase 3 for Parkinson’s despite mixed Phase 2 results. Click here to read an ...